Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma

Subclinical phaeochromocytoma

(2012) Massimo Mannelli et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Signaling Pathways in Pheochromocytomas and Paragangliomas: Prospects for Future Therapies

(2012) Svenja Nölting et al.   ENDOCRINE PATHOLOGY

Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas

(2011) Jenny Welander et al.   ENDOCRINE-RELATED CANCER

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

(2011) Iñaki Comino-Méndez et al.   NATURE GENETICS

Malignant pheochromocytomas and paragangliomas – The importance of a multidisciplinary approach

(2010) Kim Francis Andersen et al.   CANCER TREATMENT REVIEWS

MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets

(2010) Goswin Y Meyer-Rochow et al.   ENDOCRINE-RELATED CANCER

SDHA is a tumor suppressor gene causing paraganglioma

(2010) Nelly Burnichon et al.   HUMAN MOLECULAR GENETICS

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

(2010) Yuejuan Qin et al.   NATURE GENETICS

Incidental and Metastatic Adrenal Masses

(2010) Massimo Mannelli et al.   SEMINARS IN ONCOLOGY

Expression of the Transcription Factor Snail and Its Target Gene Twist Are Associated with Malignancy in Pheochromocytomas

(2009) Jens Waldmann et al.   ANNALS OF SURGICAL ONCOLOGY

High frequency of SNAIL-expressing cells confirms and predicts metastatic potential of phaeochromocytoma

(2009) V Häyry et al.   ENDOCRINE-RELATED CANCER

Novel and Evolving Therapies in the Treatment of Malignant Phaeochromocytoma: Experience with the mTOR Inhibitor Everolimus (RAD001)

(2009) M. R. Druce et al.   HORMONE AND METABOLIC RESEARCH

Sunitinib, a Novel Therapy for Anthracycline- and Cisplatin-refractory Malignant Pheochromocytoma

(2009) K.-S. Park et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Clinically Guided Genetic Screening in a Large Cohort of Italian Patients with Pheochromocytomas and/or Functional or Nonfunctional Paragangliomas

(2009) Massimo Mannelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hepatic ablation for neuroendocrine tumor metastases

(2009) Shishir K. Maithel et al.   JOURNAL OF SURGICAL ONCOLOGY

The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas

(2009) Judith Favier et al.   PLoS One

SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma

(2009) H.-X. Hao et al.   SCIENCE

Rapid degradation of hypoxia-inducible factor-1α by KRH102053, a new activator of prolyl hydroxylase 2

(2008) H J Choi et al.   BRITISH JOURNAL OF PHARMACOLOGY

Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine

(2008) Hui Huang et al.   CANCER

Heat Shock Protein 90 as a Drug Target: Some Like It Hot

(2008) U. Banerji   CLINICAL CANCER RESEARCH

TORC1 Is Essential for NF1-Associated Malignancies

(2008) Cory M. Johannessen et al.   CURRENT BIOLOGY

Rationale and Evidence for Sunitinib in the Treatment of Malignant Paraganglioma/Pheochromocytoma

(2008) Anthony M. Joshua et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and Other von Hippel-Lindau Disease-Related Tumors

(2008) Camilo Jimenez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY

Patient With Malignant Paraganglioma Responding to the Multikinase Inhibitor Sunitinib Malate

(2008) Noah M. Hahn et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis

(2008) Vivian E. Strong et al.   SURGERY

Plasma Chromogranin A or Urine Fractionated Metanephrines Follow-Up Testing Improves the Diagnostic Accuracy of Plasma Fractionated Metanephrines for Pheochromocytoma

(2007) Alicia Algeciras-Schimnich et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM